Federal contract award
36C77025P0059
ONE LINE PHARMACEUTICAL FOR THE HINES CMOP. NALTREXONE (EQV-REVIA) 50MG TAB 30CT
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Veterans Affairs |
| Office | NATIONAL CMOP OFFICE (36C770) |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | Not reported |
| Set-aside | SMALL BUSINESS SET ASIDE - TOTAL |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $0 |
| Current contract value | $0 |
| Potential contract value / ceiling | $0 |
| Start date | Dec 20, 2024 |
| Current end date | May 16, 2025 |
| Potential end date | May 16, 2025 |
| Latest award activity | May 13, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 13, 2025 | P00001 | $-196.3K | ONE LINE PHARMACEUTICAL FOR THE HINES CMOP. NALTREXONE (EQV-REVIA) 50MG TAB 30CT |
| Dec 20, 2024 | 0 | $196.3K | ONE LINE PHARMACEUTICAL FOR THE HINES CMOP. NALTREXONE (EQV-REVIA) 50MG TAB 30CT |
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.